dokumendiregister.ee
Väljaminev kiriAvalik

Euroopa farmakopöa monograafia asjus

Ravimiamet · 14. mai 2025
Viit
REP-1/2475-2
Registreeritud
14. mai 2025
Dokumendi liik
Väljaminev kiri
Adressaat
European Directorate for the Quality of Medicines & HealthCare
Funktsioon
REP Euroopa Farmakopöaga seotud asjaajamine
Sari
REP-1 Euroopa Farmakopöa alane kirjavahetus
Toimik
REP-1/2025
Vastutaja
Signe Leito (RA, Peadirektori asetäitja valdkond, Labor)

Failid

Sisu (failidest)

Survey for information of Group 10A on approved products containing difloxacin hydrochloride trihydrate for veterinary use, as well as other forms of difloxacin page 1 / 4 Q1-4 (4194) NPA: (53558) Type: (!/list-dropdown) A10 - Estonia (EE) Is difloxacin hydrochloride trihydrate used in approved medicinal products (for veterinary or human use) in your country? (53559) Type: (L/list-radio) No AO02 page 2 / 4 If yes, please list the names of the approved products and the contact details of any corresponding MAHs or information on substance manufacturers. (53560) Type: (T/text-long) - Are forms of difloxacin other than difloxacin hydrochloride trihydrate used in approved medicinal products (for veterinary or human use) in your country? (53580) Type: (L/list-radio) No AO02 If yes, please list the names of any approved products in your country that contain other forms of difloxacin and the contact details of any corresponding MAHs or information on substance manufacturers. (53561) Type: (T/text-long) - page 3 / 4 Does your country have any open-access online databases for approved veterinary medicinal products? (53581) Type: (L/list-radio) Yes AO01 If yes, we would be grateful if you could share with us links to any available databases. (53582) Type: (T/text-long) https://www.ravimiregister.ee/en/PublicHomePage.aspx Comments: (53562) Type: (T/text-long) page 4 / 4
Allikas: Ravimiamet dokumendiregister →